Brooklyn, New York, May 23, 2022 (GLOBE NEWSWIRE) -- Reports and Insights has published a new report titled, “Pharmaceutical Solubility and Bioavailability Enhancement Market: Opportunity Analysis and Future Assessment 2022-2030” analyzed by Molecule Type (Small Molecules, Biologics), By Oral Dosage Form (Oral Solid Dosage Form, Oral Liquid Dosage Form), By Technology (Particle size reduction, Lipid Solubilization Modification of Crystal Habit, Solid Dispersions, Complexation, Cryogenic Techniques, Micellar Solubilization Technology), By Excipients Type (Surfactants, Polyethylene Glycols (PEG), Polysorbates, Poloxamers, Solutol HS 15, Polyoxyl stearates, N-methyl-2-pyrrolidone, Ethanol, Glycerin, Lecithin, Docusate sodium (DSS), Sodium lauryl sulfate (SLS), Polymers, Copovidone, HPMC, Polymethacrylates (PMAs), HPMCAS, Povidone (PVP), HPC, Polyvinyl, Caprolactam-polyvinyl acetate-polyethylene glycol copolymer, PEO, HPMCP, Lipid-based excipients, Cyclodextrins, Mesoporous Silica, Dendrimers) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) is expected to grow at a significant CAGR for the period between 2022 and 2030.
Request a Free Sample Copy of the Pharmaceutical Solubility and Bioavailability Enhancement Market Research Report @ https://reportsandinsights.com/sample-request/8492
Pharmaceutical Solubility and Bioavailability Enhancement Introduction
Bioavailability speaks about the capability of a drug or other substance to be immersed and consumed by the body. Likewise, solubility demonstrates the level to which a substance dissolves in a solvent to make a solution.
The solubility and bioavailability of a pharmaceutical compound are a couple of the most crucial criterions with a view to accomplishing a coveted concentration of drug in systemic circulation for a coveted or anticipated pharmacological retort. Thereby, the solubility and bioavailability are one of the chief concerns associated with marketed pharmaceuticals, owing to which, the market is projected to grow higher over the years.
Pharmaceutical Solubility and Bioavailability Enhancement Market Dynamics
In point of fact, solubility and bioavailability are a couple of the most significant terminologies in terms of pharmaceuticals for the sake of attaining a coveted concentration of drug in systemic circulation for the coveted or estimated pharmacological response.
According to the studies, it is revealed that about 40% of available drugs are inadequately soluble/bioavailable. For that reason, an immense number of drugs fail to arrive on the market due to their poor solubility/bioavailability. Thus, there is a significant growth in the number of key players engaged in the pharmaceutical solubility and bioavailability enhancement market, ultimately boosting the market growth.
In addition to that, the growing number of chronic diseases and disorders among the population all across the world is encouraging the demand of effective drugs for better treatment of the patients, worldwide, which is also projected to play a positive role in propelling the growth of the global pharmaceutical solubility and bioavailability enhancement market in the coming years.
To view Top Players, Segmentation and other Statistics of the Pharmaceutical Solubility and Bioavailability Enhancement Industry, Read Report Description: https://reportsandinsights.com/pressrelease/pharmaceutical-solubility-and-bioavailability-enhancement-market
Pharmaceutical Solubility and Bioavailability Enhancement Market Segmentation
The global pharmaceutical solubility and bioavailability enhancement market is segmented on the basis of molecule type, oral dosage form, technology, excipients type and region.
By Molecule Type
Small Molecules
Biologics
By Oral Dosage Form
Oral Solid Dosage Form
Oral Liquid Dosage Form
By Technology
Particle size reduction
Lipid Solubilization Modification of Crystal Habit
Solid Dispersions
Complexation
Cryogenic Techniques
Micellar Solubilization Technology
By Excipients Type
Surfactants
Polyethylene Glycols (PEG)
Polysorbates
Poloxamers
Solutol HS 15
Polyoxyl stearates
N-methyl-2-pyrrolidone
Ethanol
Glycerin
Lecithin
Docusate sodium (DSS)
Sodium lauryl sulfate (SLS)
Polymers
Copovidone
HPMC
Polymethacrylates (PMAs)
HPMCAS
Povidone (PVP)
HPC
Polyvinyl
Caprolactam-polyvinyl acetate-polyethylene glycol copolymer
PEO
HPMCP
Lipid-based excipients
Cyclodextrins
Mesoporous Silica
Dendrimers
By Region
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
Request a Free Sample Report with TOC: https://reportsandinsights.com/sample-request/8492
Pharmaceutical Solubility and Bioavailability Enhancement Market Key Players
The key participating players of the global pharmaceutical solubility and bioavailability enhancement market include BASF SE, Evonik Industries AG, Lonza Group AG, Ajinomoto Althea Inc., Curia Global, Inc., Catalent, Inc., Ashland Global Specialty Chemicals Inc., DuPont de Nemours, Inc., Merck KGaA, among others002E
About Reports and Insights:
Reports and Insights is one of the leading market research companies which offers syndicate and consulting research around the globe. At Reports and Insights, we adhere to the client's needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with a strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.
